AstraZeneca: European Commission Approves Forxiga In Treatment Of Symptomatic Chronic Heart Failure
7/2 08:43
(RTTNews) - AstraZeneca (AZN, AZN.L) announced Forxiga has been approved in the European Union to extend the indication for heart failure with reduced ejection fraction to cover patients across the full spectrum of left ventricular ejection fraction, including heart failure with...